Evidence map›Paper›PMID 40583981›Full record

ArticleRadiology case reports2025

A case report of primary breast angiosarcoma: An uncommon malignancy.

Ayesha Afzal, Muhammad Junaid Tahir, Asma Asghar, Hira Yaqub, Anis Ur Rehman, Aamer Iftikhar

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayesha AfzalDepartment of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
Muhammad Junaid TahirDepartment of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
Asma AsgharDepartment of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
Hira YaqubDepartment of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
Anis Ur RehmanDepartment of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
Aamer IftikharDepartment of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiosarcoma of the breast is a rare and aggressive form of cancer that originates from vascular or lymphatic tissues, representing only 0.04% of malignant breast lesions. Variance in the clinical, pathological, and radiological presentations often leads to challenges in diagnosis. We present a case of a 32-year-old lactating female having a painless swelling in her right breast for 6 months, with a significant increase in size in 1 month. Clinical assessment indicated the presence of a mass at the superior edge of the areola, with associated bluish skin discoloration. Ultrasonography revealed a vascular lesion characterized by mixed echogenicity. A core biopsy confirmed the diagnosis of angiosarcoma. Imaging studies, including computed tomography (CT) and bone scans, ruled out distant metastases. Subsequently, surgical excision was performed, and histopathological analysis reaffirmed the diagnosis of angiosarcoma. Radiotherapy was deemed unsuitable due to the potential risk of recurrence or radiation-induced secondary angiosarcoma. This case highlights the necessity of a multidisciplinary approach in optimizing diagnosis and treatment, with surgical excision playing a pivotal role in disease management.

Indexed as

Atypical endothelial cellsPrimary angiosarcomaTumor markersUltrasoundVascular

Identifiers

PMID40583981
PMCPMC12205548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.